Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 2/2008

01-02-2008 | Original Article

Lung scintigraphy with nonspecific human immunoglobulin G (99mTc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT)

Authors: Ch. Kostopoulos, J. Koutsikos, C. Toubanakis, L. A. Moulopoulos, Ch. Mamoulakis, E. Gialafos, P. P. Sfikakis, Ch. Zerva, M. Mavrikakis, A. Leondi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2008

Login to get access

Abstract

Purpose

In patients with connective tissue diseases (CTD), the early detection and evaluation of the severity of the pulmonary involvement is mandatory. High-resolution computed tomography (HRCT) and pulmonary function tests (PFTs) are considered to be valuable noninvasive diagnostic modalities. Radiopharmaceuticals have also been used for this purpose. Our aim was the evaluation of technetium-labeled human polyclonal immunoglobulin G (HIG) lung scintigraphy in the early detection and assessment of the severity of the pulmonary involvement in CTD patients.

Methods

Fifty-two nonsmoking CTD patients were studied by PFTs, HRCT, and HIG. According to PFTs, patients were divided in group A (impaired PFTs—abnormal pulmonary function) and group B (normal pulmonary function). Semiquantitative analysis was done on HIG and HRCT and corresponding scores were obtained.

Results

Significant difference was found between HIG scores in the two groups (0.6 ± 0.07 vs 0.51 ± 0.08, P < 0.001). There was a statistically significant negative correlation between HIG scores and PFTs results and a positive correlation between HIG and HRCT scores. HIG demonstrated similar clinical performance to HRCT. At the best cut-off levels of their score (0.56 and 7, respectively), HIG had a superior sensitivity (77.5 vs 57.5%) with lower specificity (75 vs 91.7%). The combination of the two methods increased the sensitivity of abnormal findings at the expense of specificity.

Conclusions

HIG scintigraphy can be used in the early detection and evaluation of the severity of the pulmonary involvement in CTD, whereas, when used in combination with HRCT, the detection of affected patients can be further improved.
Literature
1.
Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical and serological features and survival in 1.012 Italian patients. Medicine (Baltimore) 2002;81:139–53.CrossRef
2.
Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987;91:118–27.PubMedCrossRef
3.
Cervantes-Perez P, Toro-Perez AH, Rodriquez Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA 1980;243:1715–9.PubMedCrossRef
4.
Grutters JC, Wells AU, Wuyts W, Schenk P, Leroy S, Dawson JK, et al. Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update. Eur Respir Mon 2005;10:27–49.CrossRef
5.
Latsi P, Wells A. Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr Opin Rheumatol 2003;15:748–55.PubMedCrossRef
6.
Arroliga AC, Podell DN, Matthay RA. Pulmonary manifestations of scleroderma. J Thorac Imaging 1992;7:30–45.PubMedCrossRef
7.
Kostopoulos C, Rassidakis A, Sfikakis PP, Antoniades L, Mavrikakis M. Small airways dysfunction in systemic sclerosis. A controlled study. Chest 1992;102:875–81.PubMedCrossRef
8.
Bouros D, Wells A, Nicholson A, Colby T, Polychronopoulos V, Pantelidis P, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581–86.PubMedCrossRef
9.
Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:738–42.PubMedCrossRef
10.
Diot E, Boissinot E, Asquier E, Guilmot JL, Lemarie E, Valat C, et al. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest 1998;114:1623–9.PubMed
11.
Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL, Fung PC, et al. Interstitial lung disease in systemic sclerosis. Acta Radiol 2003;44:258–64.PubMedCrossRef
12.
Afeltra A, Zennaro D, Garzia P, Gigante A, Vadacca M, Ruggiero A, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol 2006;35:388–94.PubMedCrossRef
13.
Greene N, Solinger A, Baughman. Patients with collagen vascular disease and dyspnea: The value of Gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome. Chest 1987;91:698–703.PubMedCrossRef
14.
Mogulkoc N, Brutsche MH, Bishop PW, Murby B, Greaves MS, Horrocks AW, et al. Pulmonary (99m) Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP). Thorax 2001;56:916–23.PubMedCrossRef
15.
Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, du Bois RM. Clearance of inhaled 99m Tc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993;6:797–802.PubMed
16.
Lebtahi R, Moreau S, Marchand-Adam S, Debray MP, Brauner M, Soler P, et al. Increased uptake of 111In-Octreotide in idiopathic pulmonary fibrosis. J Nucl Med 2006;47:1281–7.PubMed
17.
Rubin R, Fischman A, Gallahan R, Khaw B, Keech F, Ahmad M, et al. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med 1989;321:935–40.PubMedCrossRef
18.
de Bois MH, Arndt JW, van der Velde EA, van der Lubbe PA, Westedt ML, Pauwels EK, et al. 99mTc human immunoglobulin scintigraphy: A reliable method to detect join activity in rheumatoid arthritis. J Rheumatol 1992;19:1371–6.PubMed
19.
Buscombe JR, Lui D, Ensing G, de Jong R, Ell PJ. 99mTc-human immunoglobulin (HIG)—first results of a new agent for the localization of infection and inflammation. Eur J Nucl Med 1990;16 8–10:649–55.CrossRef
20.
Matucci-Gerinic M, D’Angelo S, Deuton C, Vlacoyiannopoulos P, Silver R. Assessment of lung involvement. Clin Exp Rheumatol 2003;21 Suppl 29:S19–23.
21.
Rossi GA, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1985;131:612–7.PubMed
22.
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.CrossRef
23.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.PubMedCrossRef
24.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.PubMedCrossRef
25.
American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107–36.
26.
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Pelsin R, Yernault JG. Lung volumes and forced ventilatory flows: report working party standardization of lung function tests. European Community for steel and coal: official statement of the European Respiratory Society. Eur Respir J 1993;6:5–40.
27.
Warrick JH, Bhalla M, Schabel SI, Silver RM. High-resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991;18:1520–8.PubMed
28.
Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests and bronchoalveolar lavage. Radiology 1993;188:499–506.PubMed
29.
Bodolay E, Szekanecz Z, Devenyi K, Galuska L, Csipo I, Vegh J. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology 2005;44:656–61.PubMedCrossRef
30.
Antoniou KM, Malagari K, Tzanakis N, Perisinakis K, Symvoulakis EK, Karkavitsas N, et al. Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis. BMC Pulm Med 2006;6:4.PubMedCrossRef
31.
de Bois MH, Arndt JW, Tak PP, Kluin PM, van der Velde EA, Pauwels EK, et al. 99Tcm-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis. Nucl Med Commun 1993;14:883–7.PubMedCrossRef
32.
Rubin RH, Fischman AJ. Radionuclide imaging of infection in the immunocompromised host. Clin Infect Dis 1996;22:414–23.PubMed
33.
Karanikas G, Babacz K, Becherer A, Wiesner K, Dudczak R, Machold K, et al. Tc-99m-labeled human polyclonal immunoglobulin G (HIG) scintigraphy in Sjögren’s syndrome. Scand J Rheumatol 2002;31:80–4.PubMedCrossRef
34.
Chouchakova N, Skokowa J, Baumann U, Tschernig T, Philippens KM, Nieswandt B, et al. FcRIII-mediated production of TNF-alpha induces immune complex alveolitis independently of CXC chemokine generation. J Immunol 2001;166:5193–200.PubMed
35.
Morrel E, Tompkins R, Fischman A. Autoradiographic method for quantitation of radiolabelled proteins in tissues using indium-111. J Nucl Med 1989;30:1538–45.
36.
Fischman AJ, Rubin RH, White A, Locke E, Wilkinson R, Nedelman M, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammatory. J Nucl Med 1990;31:1199–205.PubMed
37.
Lamblin C, Bergoin C, Saelems T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J 2001;32:695–805.
38.
39.
Steen VD, Graham G, Conte C, Owens G, Medsger TA. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992;35:765–70.PubMedCrossRef
40.
Kono H, Inokuma S. Visualization and functional consequence of pulmonary vascular impairment in patients with rheumatic diseases. Chest 2003;124:255–61.PubMedCrossRef
41.
Morgan C, Knight C, Lunt M, Black CM, Silman AJ. Predictors of end-stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 2003;62:146–50.PubMedCrossRef
42.
De Santis M, Bosello S, La Torre G, Capuano A, Tolusso B, Pagliari G, et al. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis. Respir Res 2005;6:96.PubMedCrossRef
43.
Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 2003;42:71–5.PubMedCrossRef
44.
Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 2002;6:517–21.CrossRef
45.
Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516–22.PubMedCrossRef
46.
Sfikakis PP, Kyriakidis MK, Vergos CG, Vyssoulis GP, Psarros TK, Kyriakidis CA, et al. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med 1991;90:541–6.PubMed
47.
Kim EA, Lee KS, Johkoh T, Kim TS, Suh GY, Kwon OJ, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002;22:S151–65.PubMedCrossRef
48.
Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004;232:81–91.PubMedCrossRef
Metadata
Title
Lung scintigraphy with nonspecific human immunoglobulin G (99mTc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT)
Authors
Ch. Kostopoulos
J. Koutsikos
C. Toubanakis
L. A. Moulopoulos
Ch. Mamoulakis
E. Gialafos
P. P. Sfikakis
Ch. Zerva
M. Mavrikakis
A. Leondi
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0599-7

Other articles of this Issue 2/2008

European Journal of Nuclear Medicine and Molecular Imaging 2/2008 Go to the issue

Editorial

Contralateral or bilateral lymph drainage revealed by breast lymphoscintigraphy

Original Article

Determinants of the response of left ventricular ejection fraction to vasodilator stress in electrocardiographically gated 82rubidium myocardial perfusion PET

Original Article

Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with 18F-FEDAA1106

Image of the Month

Bone scintigraphy in electrocution wounds and comparison with FDG-PET images

Original Article

CT-based attenuation correction in 82Rb-myocardial perfusion PET–CT: incidence of misalignment and effect on regional tracer distribution

Original article

Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules